
Stryker Corporation guidance
$317.49+2.18%Close 17 Nov 2026 · Market value $121.4B
In its results release of 29 Oct 2026 (Q3 FY2026), Stryker Corporation gave 2 forecasts in figures, among them EPS (adjusted) of $14.80 to $14.90 for FY2026.
Read from the company's earnings releases and outlook updates of the last two years. Each forecast is shown with the sentence or table row it was read from; what a release does not state in figures is not shown.
Latest guidance given with Q3 FY2026 results, 29 Oct 2026
| Measure | Period | Guidance | As stated |
|---|
| Organic revenue growth | FY2026 | +6.5% to +7% | We are updating our full year 2026 guidance and now expect organic net sales growth in the range of 6.5% to 7.0% and adjusted net earnings per diluted share to be in the range of $14.80 to $14.90 |
|---|
| EPS · Adjusted | FY2026 | $14.80 to $14.90 | We are updating our full year 2026 guidance and now expect organic net sales growth in the range of 6.5% to 7.0% and adjusted net earnings per diluted share to be in the range of $14.80 to $14.90 |
|---|
Source: the company's earnings release.
Guidance against results last two years
The last range given before each period closed, how it moved between releases, and the figure then filed. A measure the company defines itself, or one not comparable with the filed figure, has no verdict.
| Measure | Period | Last guidance | Revisions | Delivered | Result |
|---|
| Organic revenue growth | FY2026 | +6.5% to +7% | Lowered once | — | To come |
|---|
| EPS · Adjusted | FY2026 | $14.80 to $14.90 | Raised once, lowered once | — | To come |
|---|
SYK in the terminal
Guidance said on earnings calls, every revision charted, and guidance set against the analysts' consensus.